Making the most of your money
We’re dedicated to helping you turn your aspirations into reality
We provide you with the knowledge and research you need to make informed financial decisions you can feel confident in, so you can get back to doing the things you care about most.
Getting the best deals
We have done research on financial companies and services
Using our guides and advice, you will be able to make the best optimal decisions regarding your personal finances that will be as effective as possible.
Latest Headlines
![How to Buy Nike (NKE) Stock](https://cdnwp-s3.benzinga.com/wp-content/uploads/2018/09/27180118/jeroen-den-otter-630305-unsplash-768x513.jpg)
July 17th, 2024
How to Buy Nike (NKE) Stock
![Top Performing Meme Stocks](https://cdnwp-s3.benzinga.com/wp-content/uploads/2023/10/09134301/best-meme-stocks-768x576.jpg)
Top Performing Meme Stocks
July 17th, 2024
![Top Performing Long-Term Stocks](https://cdnwp-s3.benzinga.com/wp-content/uploads/2023/08/03164755/best-long-term-stocks-768x384.jpg)
Top Performing Long-Term Stocks
July 17th, 2024
![Top Performing Vertical Farming Stocks](https://cdnwp-s3.benzinga.com/wp-content/uploads/2023/08/10104243/916337-768x1152.jpg)
Top Performing Vertical Farming Stocks
July 17th, 2024
Reviewed by Benzinga
We review & reward the best companies in various industries
Thanks to this, you can easily choose your favorite for the services you need.
Trending
![Sam Altman's AI-Themed 'Ethereum Killer' Worldcoin Surges 40%: What's Going On?](https://www.benzinga.com/files/images/story/2024/07/17/Worldcoin-crypto.jpeg)
Sam Altman's AI-Themed 'Ethereum Killer' Worldcoin Surges 40%: What's Going On?
Worldcoin (CRYPTO: WLD) has experienced a substantial 40% price increase following an announcement by Tools for Humanity (TFH) regarding an extension o
![Roche Highlights Encouraging Data From Newly-Acquired Second Weight Loss Drug Candidate In Early-Stage Study](https://www.benzinga.com/files/images/story/2024/07/17/weight-loss-shutter2.jpeg)
Roche Highlights Encouraging Data From Newly-Acquired Second Weight Loss Drug Candidate In Early-Stage Study
Roche reported promising topline results from a Phase 1 trial of CT-996, an oral GLP-1 receptor agonist for type 2 diabetes and obesity. Participants experienced a mean weight loss of 6.1% in four weeks. CT-996 shows potential for flexible dosing.
![Bitcoin Tags $66K, ETFs Slurp Another $423M In Inflows: How High Can BTC Go?](https://www.benzinga.com/files/images/story/2024/07/17/BITCOIN-ETF.jpeg)
Bitcoin Tags $66K, ETFs Slurp Another $423M In Inflows: How High Can BTC Go?
In early Asian trading hours, Bitcoin (CRYPTO: BTC) briefly surged above $66,000, reaching a high not seen in recent weeks before settling at $64,980, a 3.7% increase.
![Jerome Powell's Top Advisor Hints At Fed's Potential Rate Cut Plans: 'All Moving In The Right Direction'](https://www.benzinga.com/files/images/story/2024/07/17/Federal-Reserve-Chair-Jerome-Powell.jpeg)
Jerome Powell's Top Advisor Hints At Fed's Potential Rate Cut Plans: 'All Moving In The Right Direction'
New York Federal Reserve President John Williams hinted at a potential interest rate cut in the coming months, suggesting that the Fed might be closer to this decision than previously thought.
What Do You Need Help With?
Mortgage
Insurance
Investing
Alternative Investing
Cryptocurrency
Personal Finance